journal article·2025-12Open access

NIR Image-Guided Multimodal Nanotherapy Synergizing Photothermal, NO Gas, and Ferroptosis Enhances Immunogenic Cell Death in Triple-Negative Breast Cancer

Menglong Zhao, Junwei Li, Xiaofeng He, Ruiqin Yang, Yongqu Zhang, Jiahui Wang, Jiatian Song, Zhiyong Wu, Tiantian Zhai, Siqi Qiu

Materials & Design· Volume 260

Abstract

• The photothermal-sensitive bioreactor, ASNP NPs, enabled a three-way treatment model, including photothermal therapy, NO gas therapy, and ferroptosis, which demonstrated a synergistic therapeutic effect in cancer treatment. • ASNP NPs promoted the release of damage-associated molecular patterns and reprogrammed the tumor immune microenvironment to establish more effective tumoricidal immunity. • ASNP NPs significantly inhibited tumor growth in a 4T1 tumor-bearing mouse model and prevented local tumor recurrence. • ASNP NPs demonstrated a photothermal effect and the ability of NO and ·OH production in fresh human breast cancer tissue, indicating its potential for clinical translation. Immunogenic cell death (ICD), which relies on the release of damage-associated molecular patterns (DAMPs), is able to induce a powerful immune response and improve the antitumor treatment efficacy. Unfortunately, traditional ICD inducers are limited by insufficient release of DAMPs, greatly diminishing their antitumor effects. Here, a multifunctional bioreactor (ASNP NPs) was developed to effectively activate ICD by increasing the release of DAMPs. Specifically, photothermal agent (aza-BODIPY-4C8) and sodium nitroprusside (SNP) were encapsulated into thermally sensitive liposomes to obtain the photothermal-sensitive ASNP NPs. Under irradiation with near-infrared light, ASNP NPs generated heat and released SNP. SNP reacted with glutathione (GSH) to produce NO and Fe 2+ . Fe 2+ further reacted with H 2 O 2 to generate hydroxyl radical (·OH). This further promoted ferroptosis in tumor cells. Together, the photothermal, NO gas, and ferroptosis multimodal therapy by ASNP NPs effectively promoted the release of DAMPs. Importantly, the enhanced ICD effect induced by ASNP NPs reprogrammed the tumor immune microenvironment to establish more effective tumoricidal immunity. This synergistic treatment strategy significantly inhibited tumor growth in a 4T1 tumor-bearing mouse model. Furthermore, the photothermal effect and NO and ·OH production induced by ASNP NPs was observed in fresh human breast cancer tissues, indicating its potential for clinical translation.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Ferroptosis and cancer prognosis · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (51)

Show source-provided references
1. Cancer incidence and mortality in China
2. Triple-negative breast cancer: clinical features and patterns of recurrence10.1158/1078-0432.CCR-06-3045 ↗
3. Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute’s Surveillance, Epidemiology, and end results database10.1002/cncr.22836 ↗
4. Cancer immunotherapy with immune checkpoint inhibitors (ICIs): potential, mechanisms of resistance, and strategies for reinvigorating T cell responsiveness when resistance is acquired10.1186/s12935-023-02902-0 ↗
5. Recent advances in immune checkpoint inhibitors for triple-negative breast cancer10.2147/ITT.S495751 ↗
6. Targeting immunogenic cell stress and death for cancer therapy10.1038/s41573-024-00920-9 ↗
7. Immunogenic cell death and DAMPs in cancer therapy10.1038/nrc3380 ↗
8. Synergistic reinforcing of immunogenic cell death and transforming tumor-associated macrophages via a multifunctional cascade bioreactor for optimizing cancer Immunotherapy10.1002/adma.202207593 ↗
9. Manipulating calcium homeostasis with nanoplatforms for enhanced cancer therapy
10. Strategically designed mitochondria-targeting AIEgens for effective eradication of primary and metastatic tumors via synergistic phototherapy and induced immunogenic cell death10.1002/adhm.202500513 ↗
11. Biomimetic nanoparticles for effective mild temperature photothermal therapy and multimodal imaging10.1016/j.jconrel.2022.05.010 ↗
12. An autocatalytic multicomponent DNAzyme nanomachine for tumor-specific photothermal therapy sensitization in pancreatic cancer10.1038/s41467-023-42740-2 ↗
13. Recent strategies for nano-based PTT combined with immunotherapy: from a biomaterial point of view10.7150/thno.56482 ↗
14. HSP70 family in cancer: signaling mechanisms and therapeutic advances10.3390/biom13040601 ↗
15. T lymphocyte-derived immunogenic hybrid nanovesicles for immunosuppression reversion and boosted photothermal immunotherapy10.1016/j.nantod.2024.102148 ↗
16. Inducing immunogenic cancer cell death through oxygen-economized photodynamic therapy with nitric oxide-releasing photosensitizers
17. Nitric oxide (NO) and NO synthases (NOS)-based targeted therapy for colon cancer10.3390/cancers12071881 ↗
18. Near-infrared light-responsive nitric oxide microcarrier for multimodal tumor therapy
19. Ferroptosis: mechanisms and links with diseases10.1038/s41392-020-00428-9 ↗
20. Emerging strategies of cancer therapy based on ferroptosis
21. Transformable supramolecular self-assembled peptides for cascade self-enhanced ferroptosis primed cancer immunotherapy
22. Cascade loop of ferroptosis induction and immunotherapy based on metal-phenolic networks for combined therapy of colorectal cancer
23. Biomineralized bacterial outer membrane vesicles potentiate safe and efficient tumor microenvironment reprogramming for anticancer therapy
24. Perturbing organelle-tevel K+/Ca2+ homeostasis by nanotherapeutics for enhancing ion-mediated cancer immunotherapy10.1002/adma.202416574 ↗
25. Ferroptosis in immunostimulation and immunosuppression10.1111/imr.13235 ↗
26. A novel NIR-controlled NO release of sodium nitroprusside-doped Prussian blue nanoparticle for synergistic tumor treatment10.1016/j.biomaterials.2019.05.024 ↗
27. Dominant roles of Fenton reaction in sodium nitroprusside-induced chondrocyte apoptosis10.1016/j.freeradbiomed.2016.02.026 ↗
28. Bimetallic nanoreactor mediates cascade amplification of oxidative stress for complementary chemodynamic-immunotherapy of tumor10.1016/j.biomaterials.2024.123075 ↗
29. A photothermally-induced HClO-releasing nanoplatform for imaging-guided tumor ablation and bacterial prevention10.1039/D0BM01629B ↗
30. Halogenated aza-BODIPY for imaging-guided synergistic photodynamic and photothermal tumor therapy10.1002/adhm.201800606 ↗
31. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method10.1038/nprot.2006.378 ↗
32. A colorimetric and fluorometric dual-mode carbon dots probe derived from phenanthroline precursor for the selective detection of Fe2+ and Fe3+
33. Fe(III)-naphthazarin metal-phenolic networks for glutathione-depleting enhanced ferroptosis-apoptosis combined cancer therapy
34. Current advances of nitric oxide in cancer and anticancer therapeutics10.3390/vaccines9020094 ↗
35. Gold nanorods together with HSP inhibitor-VER-155008 micelles for colon cancer mild-temperature photothermal therapy10.1016/j.apsb.2018.05.011 ↗
36. Nitric oxide-driven nanotherapeutics for cancer treatment10.1016/j.jconrel.2023.08.038 ↗
37. Stearoyl-CoA desaturase 1 protects ovarian cancer cells from ferroptotic cell death10.1158/0008-5472.CAN-19-0369 ↗
38. Activatable plasmonic versatile nanoplatform for glutathione-depletion augmented ferroptosis and NIR-II photothermal synergistic therapy10.1021/acsmaterialslett.3c01533 ↗
39. Near-infrared laser-triggered nitric oxide nanogenerators for the reversal of multidrug resistance in cancer10.1002/adfm.201606398 ↗
40. A nitric oxide-boosting molecular agent to enhance mild-temperature photothermal therapy10.1039/D5CC00219B ↗
41. Self-catalyzed nitric oxide nanocomplexes induce ferroptosis for cancer immunotherapy10.1016/j.jconrel.2024.11.048 ↗
42. Inhalable biomimetic polyunsaturated fatty acid-based nanoreactors for peroxynitrite-augmented ferroptosis potentiate radiotherapy in lung cancer10.1186/s12951-025-03409-8 ↗
43. Emerging nitric oxide gas-assisted cancer photothermal treatment
44. Coordinating the mechanisms of action of ferroptosis and the photothermal effect for cancer theranostics10.1002/anie.202112925 ↗
45. Emerging roles of energy metabolism in ferroptosis regulation of tumor cells
46. DAMPs and DAMP-sensing receptors in inflammation and diseases10.1016/j.immuni.2024.03.002 ↗
47. Tumor-associated macrophages in breast cancer: innocent bystander or important player?10.1016/j.ctrv.2018.08.010 ↗
48. Combined photodynamic and photothermal therapy and immunotherapy for cancer treatment: a review10.2147/IJN.S388996 ↗
49. Biomineralized engineered bacterial outer membrane vesicles as cGAS-STING nanoagonists synergize with lactate metabolism modulation to potentiate immunotherapy10.1021/jacs.5c05148 ↗
50. Cerenkov iuminescence-induced NO release from 32P-labeled ZnFe(CN)5NO nanosheets to enhance radioisotope-immunotherapy10.1016/j.matt.2019.07.007 ↗
51. Molecular and biochemical aspects of the PD-1 checkpoint pathway10.1056/NEJMra1514296 ↗